Skip to main content
Log in

Evidenzbasierte EULAR-Empfehlungen zum Management einer systemischen Glukokortikoid-Therapie bei rheumatischen Erkrankungen

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

  • Standpunkte
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Hoes JN, Jacobs JW, Boers M et al (2007) EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66:1560–1567

    Article  PubMed  CAS  Google Scholar 

  2. Kirwan JR, Bijlsma JW, Boers M, Shea BJ (2007) Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev:CD006356

    Google Scholar 

  3. Midtvedt K, Hjelmesaeth J, Hartmann A et al (2004) Insulin resistance after renal transplantation the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 15:3233–3239

    Article  PubMed  Google Scholar 

  4. Buttgereit F, Doering G, Schaeffler A et al (2008) Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1) a double-blind, randomised controlled trial. Lancet 371:205–214

    Article  PubMed  CAS  Google Scholar 

  5. Da Silva JA, Jacobs JW, Kirwan JR et al (2006) Safety of low dose glucocorticoid treatment in rheumatoid arthritis published evidence and prospective trial data. Ann Rheum Dis 65:285–293

    Article  Google Scholar 

  6. de Nijs RN, Jacobs JW, Algra A et al (2004) Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int 15:589–602

    Google Scholar 

  7. Hooper L, Brown TJ, Elliott R et al (2004) The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs systematic review. BMJ 329:948

    Article  PubMed  CAS  Google Scholar 

  8. Deeks JJ, Smith LA, Bradley MD (2002) Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis systematic review of randomised controlled trials. BMJ 325:619

    Article  PubMed  CAS  Google Scholar 

  9. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P (1992) The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326:226–230

    PubMed  CAS  Google Scholar 

  10. Simon D, Fernando C, Czernichow P, Prieur AM (2002) Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol 29:1296–3000

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Kolar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolar, P., Buttgereit, F. Evidenzbasierte EULAR-Empfehlungen zum Management einer systemischen Glukokortikoid-Therapie bei rheumatischen Erkrankungen. Z. Rheumatol. 68, 349–352 (2009). https://doi.org/10.1007/s00393-008-0420-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-008-0420-4

Navigation